CPDA-1 17.3 mg/63mL
Anticoagulant Citrate Phosphate Dextrose Adenine · SOLUTION · Fenwal, Inc.
CPDA-1 is a solution containing anticoagulant citrate phosphate dextrose adenine at 17.3 mg/63mL, taken intravenous. Manufactured by Fenwal, Inc..
Key Facts
- Brand Name
- CPDA-1
- Generic Name
- Anticoagulant Citrate Phosphate Dextrose Adenine
- NDC Code (Product)
0942-9398- Manufacturer
- Fenwal, Inc.
- Strength
- 17.3 mg/63mL
- Dosage Form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BN770420
- Drug Class
- Calculi Dissolution Agent [EPC]; Anti-coagulant [EPC]
- Marketing Start
- 03/01/2007
Recall History
No Recall HistoryFrequently Asked Questions
What is CPDA-1 used for?
CPDA-1 contains Anticoagulant Citrate Phosphate Dextrose Adenine. It is a solution taken intravenous. Consult your doctor for specific uses.
Is CPDA-1 a controlled substance?
CPDA-1 is not classified as a controlled substance by the DEA.
What is the generic name for CPDA-1?
The generic name for CPDA-1 is Anticoagulant Citrate Phosphate Dextrose Adenine. There are no other listed brand versions of Anticoagulant Citrate Phosphate Dextrose Adenine.
What is the NDC code for CPDA-1 17.3 mg/63mL?
The NDC (National Drug Code) for CPDA-1 17.3 mg/63mL is 0942-9398, listed by Fenwal, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)